Viewing Study NCT05282459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2026-01-01 @ 10:25 PM
Study NCT ID: NCT05282459
Status: COMPLETED
Last Update Posted: 2025-03-20
First Post: 2022-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Sponsor: Stanford University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module